Legend Biotech (LEGN) Free Cash Flow Growth (1y) (2020 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 60.84% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 88.70% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -15.72% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 66.37% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 3.98% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 137.65% |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 88.70% |
| Sep 30, 2025 | 145.83% |
| Jun 30, 2025 | -315.95% |
| Mar 31, 2025 | -567.59% |
| Dec 31, 2024 | 17.90% |
| Sep 30, 2024 | -32.96% |
| Jun 30, 2024 | 101.93% |
| Mar 31, 2024 | 116.13% |
| Dec 31, 2023 | -356.25% |
| Sep 30, 2023 | 20.22% |
| Jun 30, 2023 | -8,513.94% |
| Mar 31, 2023 | -102.71% |
| Dec 31, 2022 | 81.56% |
| Sep 30, 2022 | -110.00% |
| Jun 30, 2022 | 97.59% |
| Mar 31, 2022 | -484.96% |
| Dec 31, 2021 | 20.58% |
| Sep 30, 2021 | 42.19% |
| Jun 30, 2021 | 22.49% |
| Mar 31, 2021 | 75.15% |
| Dec 31, 2020 | -227.99% |
| Sep 30, 2020 | -387.16% |
| Jun 30, 2020 | -46.74% |